必利停錠 structure

必利停錠

TL;DR: 必利停錠 (CAS 202189-78-4) is a chemical compound with molecular formula C14H16ClNO and molecular weight 249.09 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.

必利停錠

(4aS,10bS)-8-chloro-4-methyl-1,2,4a,5,6,10b-hexahydrobenzo[f]quinolin-3-one

Also Known As: Bexlosteride, LY 191704, HY-118091B, 8-Chloro-4-methyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolin-3(2H)-one, (4aS,10bS)-8-chloro-4-methyl-1,2,4a,5,6,10b-hexahydrobenzo[f]quinolin-3-one

CAS: 202189-78-4
Molecular Formula C14H16ClNO
Molecular Weight 249.09 g/mol
LogP 2.6
Topological Polar Surface Area 20.3 Ų
Hydrogen Bond Donors 0
Hydrogen Bond Acceptors 1
Rotatable Bonds 0
Exact Mass 249.09204
Heavy Atoms 17
Complexity 319.0

Chemical Identifiers

CAS Number 202189-78-4
SMILES CN1[C@H]2CCC3=C([C@@H]2CCC1=O)C=CC(=C3)Cl
InChIKey WQBIOEFDDDEARX-STQMWFEESA-N

Patent-Derived Application Labels

Derived from 3 IPC patent classification(s) across the SureChEMBL global patent database.

Heterocyclic Building Blocks (17 patents) Organic Building Blocks (12 patents) Pharmaceutical Intermediates (17 patents)

Product Overview

必利停錠 (CAS 202189-78-4), with molecular formula C14H16ClNO and molecular weight 249.09 g/mol. IUPAC: (4aS,10bS)-8-chloro-4-methyl-1,2,4a,5,6,10b-hexahydrobenzo[f]quinolin-3-one.

🧪
Safety Data Sheet (MSDS / SDS) View the Laboratory Chemical Safety Summary (LCSS) on PubChem — includes GHS classifications, hazard statements, first aid measures, and handling precautions.
View MSDS →

Chemical Property Profile of 必利停錠

XLogP
2.6
TPSA (Topological Polar Surface Area)
20.3
Hydrogen Bond Donors
0
Hydrogen Bond Acceptors
1
Rotatable Bonds
0
Heavy Atoms
17
Complexity
319.0
Exact Mass
249.09204
Monoisotopic Mass
249.09204
Data Source: Chemical property values are referenced from PubChem, the world's largest open chemistry database maintained by the National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine.

Property Insights of 必利停錠

The XLogP value of 2.6 suggests moderate lipophilicity, balancing water solubility and membrane permeability for 必利停錠. With a topological polar surface area (TPSA) of 20.3 Ų, 必利停錠 exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 必利停錠 has 0 hydrogen bond donor(s) and 1 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.

Frequently Asked Questions

What is the typical lead time for this product?
Lead time typically ranges from 3-7 business days for in-stock items. For larger quantities or custom orders, please contact us for specific lead times.
Can you provide samples for testing?
Yes, we offer sample quantities for quality testing. Please submit an inquiry with your requirements and we will arrange samples accordingly.
What documentation do you provide with the product?
We provide COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), and technical data sheets with each shipment.
Do you ship internationally?
Yes, we ship to most countries worldwide. Shipping costs and delivery times vary by location. Please contact us for specific shipping information.

Frequently Asked Questions

What is the CAS number of 必利停錠?

The CAS number of 必利停錠 is 202189-78-4.

What is the molecular formula of 必利停錠?

The molecular formula of 必利停錠 is C14H16ClNO.

What is the molecular weight of 必利停錠?

The molecular weight of 必利停錠 is 249.09 g/mol.

Where can I buy 必利停錠?

You can request a quote for 必利停錠 directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.

Does KEHONG BIO offer custom synthesis for 必利停錠?

Yes, KEHONG BIO provides custom synthesis services for 必利停錠 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.

🤖 科弘生物 AI 助手 ×
您好!我是 科弘生物 AI 助手。可以问我产品搜索、询价、样品或技术问题。如何帮助您?